Abstract:Aim: We aimed to systematically examine the effects of enzymatic activity of 38 human CYP2C9 alleles and 21 human CYP3A4 alleles, including wild-type CYP2C9.1 and CYP3A4.1, which contain the 24 CYP2C9 novel alleles (*36*60) and 6 CYP3A4 novel alleles (*28-*34) newly found in the Chinese population, on sildenafil metabolism through in vitro experiment.Methods: The recombinant cytochrome P450 alleles protein of CYP2C9 and CYP3A4 expressed in insect baculovirus expression system were reacted with 10-500 mu M sildenafil for 30 minutes at 37 degrees C, and the reaction was terminated by cooling to -80 degrees C immediately. Next, we used ultra-performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) detection system to detect sildenafil and its active metabolite N-desmethyl sildenafil.Results: The intrinsic clearance (Vmax/Km) values of most CYP2C9 variants were significantly altered when compared with the wild-type CYP2C9*1, with most of these variants exhibiting either reduced Vmax and/or increased Km values. Four alleles (CYP2C9*11, *14, *31, *49) exhibited no markedly decreased relative clearance (1-fold). The relative clearance of the remaining thirty-three variants exhibited decrease in different levels, ranging from 1.81% to 88.42%. For the CYP3A4 metabolic pathway, when compared with the wild-type CYP3A4*1, the relative clearance values of four variants (CYP3A4*3, *10, *14 and *I3357) showed significantly higher relative clearance (130.7-134.9%), while five variants (CYP3A4*2, *5, *24, *L22Vand *F1131) exhibited sharply reduced relative clearance values (1.80-74.25%), and the remaining nine allelic variants showed no statistical difference. In addition, the kinetic parameters of two CYP3A4 variants (CYP3A4*17 and CYP3A4*30) could not be detected, due to the defect of the CYP3A4 gene.Conclusion: These findings were the first evaluation of all these infrequent CYP2C9 and CYP3A4 alleles for sildenafil metabolism; when treating people who carry these CYP2C9 and CYP3A4 variants, there should be more focus on the relation of dose intensity, side effects and therapeutic efficacy when administering sildenafil The study will provide fundamental data on effect of CYP2C9 and CYP3A4 allelic variation on sildenafil metabolism for further clinical research.

The Influence of CYP3A5*3 and BCRPC421A Genetic Polymorphisms on the Pharmacokinetics of Felodipine in Healthy Chinese Volunteers.

Impact of 14 Types of Genetic Polymorphisms on Antihypertensive Efficacy of Felodipine in Healthy Chinese Subjects

Identification and Functional Assessment of EightCYP3A4Allelic Variants39–46Detected in the Chinese Han Population

TRIB3 Rs6037475 is a Potential Biomarker for Predicting Felodipine Drug Response in Chinese Patients with Hypertension.

CYP3A53 and CYP3A418 Single Nucleotide Polymorphisms in a Chinese Population.

Effect of Cytochrome P450 Oxidoreductase Ala503Val Genotype on the Pharmacokinetics of Amlodipine in Healthy Chinese Subjects

CYP2C19 681G > A Polymorphism and Pharmacokinetics of Clopidogrel in Chinese Healthy Volunteers.

Effects of Cyp3a5, Mdr1 and Cacna1c Polymorphisms on the Oral Disposition and Response of Nimodipine in A Chinese Cohort

Effects of CYP3A41G and CYP3A53 Polymorphisms on Pharmacokinetics of Tylerdipine Hydrochloride in Healthy Chinese Subjects

ABCB1 Polymorphism and Gender Affect the Pharmacokinetics of Amlodipine in Chinese Patients with Essential Hypertension: A Population Analysis

A Functional Polymorphism in the Cyp3a4 Gene is Associated with Increased Risk of Coronary Heart Disease in the Chinese Han Population

Effect of CYP4F2 Polymorphisms on Ticagrelor Pharmacokinetics in Healthy Chinese Volunteers.

Systematic Screening for Polymorphisms in the CYP3A4 Gene in the Chinese Population.

Effects of polymorphic gene on the pharmacokinetics and pharmacodynamics of amlodipine

Relationship of CYP2C192 and CYP2C193 Gene Polymorphism with Clopidogrel Response Variability and Recurrent Cardiovascular Events in Chinese Patients Undergoing Percutaneous Coronary Intervention.

Effect of CYP3A4∗1G and CYP3A5∗3 Polymorphisms on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese Subjects

Association Between CYP2C19 and ABCB1 Polymorphisms and Clopidogrel Resistance in Clopidogrel-Treated Chinese Patients

Effects of Genetic Factors on the Pharmacokinetics and Pharmacodynamics of Amlodipine in Primary Hypertensive Patients.

Functional Measurement Of Cyp2c9 And Cyp3a4 Allelic Polymorphism On Sildenafil Metabolism

Influence of Cyp2d6*10b Genotype on Pharmacokinetics of Propafenone Enantiomers in Chinese Subjects

Association Between Cytochrome P450 2C19 Polymorphism and Clinical Outcomes in Chinese Patients with Coronary Artery Disease